Dr. Gregory Spana, MD

Dr. Spana practices at Delaware Surgery Center, LLC - HOPD in Dover, Delaware.

Dr. Spana's NPI, 1639314628, was assigned on December 5, 2008. Dr. Spana graduated from Jefferson Medical College of Thomas Jefferson University in 2004. Dr. Spana holds Delaware license C1-0009647.

Dr. Spana's primary practice is Delaware Surgery Center, LLC - HOPD, at 200 Banning St, Dover, DE 19904.

Dr. Spana's primary practice is Delaware Surgery Center, LLC - HOPD in Dover, Delaware. Dr. Spana is also affiliated with Bayhealth Hospital, Kent Campus. The medical group on file is Urology Associates of Delaware. Dmand AI also links Dr. Spana to 3 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spana practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Spana's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Spana is licensed in Delaware.

CMS data shows 20,752 Medicare services from Dr. Spana across 45 procedure codes in 2024, for 1,192 Medicare patients. Medicare paid $478,448 for them.

CMS counts 1,192 Medicare patients who saw Dr. Spana in 2024. The largest group is 65 to 74, with 517 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spana's median patient age at 70, with 25% women.

In 2024, Dr. Spana wrote 2,060 Medicare Part D claims for 592 patients. 84% of them were for generic drugs. CMS names the drug for 1,841 of them, across 30 drugs with 11 or more claims each, at $1,097,499 in total drug cost. In 2023, CMS named 1,802 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Spana for performance year 2024, reported as part of a group. Dr. Spana accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Spana as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Spana, published from 2010 to 2012. 2011 was the busiest year, with 7. The most frequent topics are Robotics, Nephrectomy and Kidney Neoplasms. Dr. Spana has published most often in BJU Int. Dr. Spana's most frequent co-authors are Rakesh Khanna, MD, Shahab P. Hillyer, MD and Michael Anthony White, DO.

CMS Open Payments shows 431 general payments to Dr. Spana from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Astellas Pharma US Inc paid the most, $1,145.

Dr. Spana graduated from Jefferson Medical College of Thomas Jefferson University in 2004.